National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

Rights & Permissions

topleft topright

Options for Poliomyelitis Vaccination in the United States: Workshop Summary (1996)
Institute of Medicine (IOM)

Citation Manager

. "AFTERWORD." Options for Poliomyelitis Vaccination in the United States: Workshop Summary. Washington, DC: The National Academies Press, 1996.

Please select a format:

BibTeX EndNote RefMan


Page
32
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Options for Poliomyelitis Vaccination in the United States: Workshop Summary

implementation, which will be presented to the entire committee at its October meeting. Combination vaccines that include IPV will enhance implementation by minimizing the number of injections needed. Until a new policy is developed and implemented, the ACIP reaffirms its current polio vaccination policy.

After a meeting of the ACIP on June 20, 1996, the CDC released a media advisory that read in part:

CDC's Advisory Committee on Immunization Practices (ACIP) today voted to change the recommendation for routine childhood polio vaccination. To decrease the occurrence of vaccine-associated paralytic polio, the committee's recommendation is that children in the United States receive two doses of inactivated polio vaccine (IPV) followed by two doses of oral polio vaccine (OPV). The ACIP continues to believe that both the four-dose schedule of OPV, currently routinely recommended, and the alternate four-dose schedule of IPV remain acceptable options for childhood immunization.

This recommendation follows a 2-year review by ACIP of the current policy, written in 1982. The CDC will now evaluate the recommendation. Until the CDC decides on the recommendation, CDC reaffirms the ACIP 's current polio vaccination policy that relies primarily on OPV for prevention of polio in the United States. Parents should be made aware of the polio vaccines available and the reasons why these recommendations are made. The benefits and risks of the vaccines for individuals and the community should be stated so that vaccination is carried out among persons who are fully informed.

Page
32